Company profile for LenioBio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

LenioBio is a life science biotech offering a disruptive protein expression technology.ALiCE® is the first eukaryotic cell-free protein expression platform that is scalable and changes the way proteins are produced today, across all industries. ALiCE enables the discovery, development and production of difficult-to-express proteins.Founded in 2016 with a clear purpose, we built a team of highly committed specialists from b...
LenioBio is a life science biotech offering a disruptive protein expression technology.ALiCE® is the first eukaryotic cell-free protein expression platform that is scalable and changes the way proteins are produced today, across all industries. ALiCE enables the discovery, development and production of difficult-to-express proteins.Founded in 2016 with a clear purpose, we built a team of highly committed specialists from business and science.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Erkrather Str. 401 40231 Düsseldorf
Telephone
Telephone
+49 (0) 211 8909 40300
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/maibe-and-leniobio-announce-a-new-strategic-collaboration-aimed-at-accelerating-the-discovery-and-experimental-validation-of-next-generation-monoclonal-antibodies-302625972.html

PR NEWSWIRE
26 Nov 2025

https://www.prnewswire.com/news-releases/leniobio-secures-eur-3-7m-of-eu4health-funding-to-develop-alice-for-cost-effective-and-rapid-production-of-protein-based-medicines-302511100.html

PR NEWSWIRE
23 Jul 2025

https://www.recipharm.com/press-releases/leniobio-collaborates-recibiopharm-scale-alicer-technology-and-expedite-vaccine-production

PRESS RELEASE
02 Oct 2024
Touchlight and LeninBio announce link up
Touchlight and LeninBio announce link up

02 Jul 2024

// PRESS RELEASE

https://www.touchlight.com/news/touchlight-and-leniobio-collaborate-to-accelerate-development-of-protein-therapeutics-for-pandemic-response/

PRESS RELEASE
02 Jul 2024

https://www.prnewswire.com/news-releases/leniobio-appoints-hugh-watson-as-chief-financial-officer-302029712.html

PR NEWSWIRE
11 Jan 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty